Lpath Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
7,986.80
5,080.50
67,790.00
64,650.00
64,310.00
Cost of Goods Sold (COGS) incl. D&A
-
-
27,336.00
32,448.00
31,818.00
Gross Income
-
-
40,454.00
32,202.00
32,492.00
SG&A Expense
15,381.80
22,669.40
57,137.00
49,363.00
54,931.00
EBIT
7,591.30
17,805.10
-
-
22,439.00
Unusual Expense
1,000.00
1,250.00
-
3,600.00
-
Non Operating Income/Expense
26.60
0.00
663.00
1,851.00
41.00
Interest Expense
-
-
10,036.00
18,168.00
4,508.00
Pretax Income
6,564.70
16,555.10
27,382.00
40,780.00
26,988.00
Income Tax
-
-
49.00
387.00
304.00
Consolidated Net Income
6,564.70
16,555.10
27,431.00
41,167.00
27,292.00
Net Income
6,564.70
16,555.10
27,431.00
41,167.00
27,292.00
Net Income After Extraordinaries
6,564.70
16,555.10
27,431.00
41,167.00
27,292.00
Net Income Available to Common
6,564.70
16,555.10
36,382.00
41,167.00
27,292.00
EPS (Basic)
37.74
77.01
11,698.23
105.69
2.01
Basic Shares Outstanding
174.50
215.00
3.10
389.50
13,565.80
EPS (Diluted)
37.62
77.01
11,698.42
105.69
2.01
Diluted Shares Outstanding
174.50
215.00
3.10
389.50
13,565.80
EBITDA
7,395.10
17,589.00
8,623.00
8,069.00
12,722.00
Preferred Dividends
-
-
8,951.00
-
-

About Lpath

View Profile
Address
1120 South Capital of Texas Highway
Austin Texas 78746
United States
Employees -
Website http://www.apolloendo.com
Updated 09/14/2018
Apollo Endosurgery, Inc. is a medical technology company, which engages in the design, development, and commercialization of medical devices. It offers medical devices for bariatric and gastrointestinal procedures under the Orbera, Lap-band SYSTEM, and OverStitch brands. The company was founded by Christopher J.